Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

Clinical trial NCT00067470 · COMPLETED

Trial details

NCT number: NCT00067470
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis VI

Start date: 2003-09-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.